Alisa Lask
CIK 1767593 · last filed 2025-01-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$162.4K
Companies
2
Total Filings
13
Lifetime Open-Market Net
$1.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NEPH | Director | 48,629 | $3.34 | $162.4K | $1.6K | 8 | 2025-01-03 |
| RVL Pharmaceuticals plc (RVLP) Delisted | Director | 112,557 | $0.03 | $3.2K | $0 | 3 | 2023-08-14 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-09-13 | NEPH | Buy (P) | +250 | $1.6K | EDGAR |
| 2019-05-02 | — | Grant (A) | — | $0 | |
| 2019-02-12 | — | Grant (A) | — | $0 |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.